Publication | Closed Access

Phase Ib/IIa randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with CHB

VaccinationViral HepatitisImmunologyAntiviral TherapyHepatitisVirologyAntiviral ResponsePhase Ib/iiaVirally-suppressed PatientsLow-dose NivolumabImmunotherapyMedicine